Ardelyx reported $5.6M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
Amgen USD 95.64B 94.98B Jun/2026
Ardelyx USD 5.6M 160K Mar/2026
aTyr Pharma 79.65M 78.89M Mar/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Curis USD 178K 441K Dec/2023
Sanofi EUR -25M 99.78M Dec/2025
TG Therapeutics USD 16.57M 8.91M Jun/2026
United Therapeutics USD 2.9M 200K Jun/2026